Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
3192 |
|
| Actual shortage: | 254 (8%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2927 (92%) | |
Discontinuation Reports |
435 |
|
| To be discontinued: | 2 (0%) | |
| Discontinued: | 410 (94%) | |
| Reversed: | 23 (5%) | |
Late reports |
482 (13%) |
|
Overdue reports |
11 (4%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-PREGABALIN | 25MG | CAPSULE | Resolved | 2022-06-09 | 2023-06-09 | 162254 |
| TEVA-PREGABALIN | 75MG | CAPSULE | Resolved | 2022-06-09 | 2023-06-09 | 162257 |
| TEVA-PREGABALIN | 150MG | CAPSULE | Resolved | 2022-06-09 | 2023-06-09 | 162260 |
| TEVA-PREGABALIN | 225MG | CAPSULE | Resolved | 2022-06-09 | 2023-06-09 | 162265 |
| TEVA-PREGABALIN | 150MG | CAPSULE | Resolved | 2025-08-14 | 2025-09-04 | 265220 |
| TEVA-PREGABALIN | 75MG | CAPSULE | Resolved | 2025-10-02 | 2025-11-27 | 268449 |
| TEVA-PREGABALIN | 300MG | CAPSULE | Resolved | 2025-10-02 | 2025-11-27 | 268452 |
| TEVA-PROCTOSONE | 5MG 5MG 10MG 10MG | OINTMENT | Resolved | 2019-07-02 | 2025-04-25 | 88222 |
| TEVA-PROCTOSONE | 5MG 5MG 10MG 10MG | OINTMENT | Resolved | 2019-07-02 | 2025-04-25 | 88225 |
| TEVA-PROFEN | 600MG | TABLET | Resolved | 2018-03-13 | 2018-05-30 | 42597 |
| TEVA-PROGESTERONE | 100MG | CAPSULE | Resolved | 2017-08-02 | 2017-10-10 | 17983 |
| TEVA-PROGESTERONE | 100MG | CAPSULE | Resolved | 2020-05-01 | 2020-06-04 | 113746 |
| TEVA-PROGESTERONE | 100MG | CAPSULE | Resolved | 2020-06-04 | 2020-06-25 | 116681 |
| TEVA-PROGESTERONE | 100MG | CAPSULE | Resolved | 2020-12-17 | 2021-02-11 | 130288 |
| TEVA-PROGESTERONE | 100MG | CAPSULE | Resolved | 2021-01-28 | 2021-03-18 | 132633 |
| TEVA-PROGESTERONE | 100MG | CAPSULE | Resolved | 2021-05-20 | 2021-07-09 | 139740 |
| TEVA-PROGESTERONE | 100MG | CAPSULE | Resolved | 2021-06-24 | 2022-04-28 | 141480 |
| TEVA-PROGESTERONE | 100MG | CAPSULE | Resolved | 2021-09-02 | 2022-04-28 | 145127 |
| TEVA-PROGESTERONE | 100MG | CAPSULE | Resolved | 2023-04-27 | 2023-06-30 | 190704 |
| TEVA-PROGESTERONE | 100MG | CAPSULE | Actual shortage | 2023-06-16 | 2025-10-14 | 195153 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-VALSARTAN | 40MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258501 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255827 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255830 |
| TEVA-VALSARTAN/HCTZ | 25MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255833 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256140 |
| TEVA-VALSARTAN/HCTZ | 25MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256143 |
| TEVA-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-02-07 | 2020-02-08 | 105537 |
| TEVA-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-06-11 | 2020-06-11 | 117546 |
| TEVA-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-09-24 | 2020-09-24 | 124899 |
| TEVA-VORICONAZOLE | 200MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256166 |
| TEVA-VORICONAZOLE | 50MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256169 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-09-27 | 2019-10-01 | 94980 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-10-17 | 2019-10-17 | 96695 |
| ZOLEDRONIC ACID FOR INJECTION | 4MG | SOLUTION | Discontinued | 2025-05-28 | 2025-05-28 | 258583 |
| ZOLEDRONIC ACID INJECTION | 5MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14030 |